Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 20:15:141.
doi: 10.1186/s12881-014-0141-2.

Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation

Affiliations

Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation

Xiao Liu et al. BMC Med Genet. .

Abstract

Background: Pompe disease is an autosomal recessive lysosomal glycogen storage disorder that has been reported in different ethnic populations which carry different common mutations of the acid alpha-glucosidase (GAA) gene. The GAA mutation pattern in mainland Chinese patients with late-onset Pompe disease is still not well understood.

Methods: We presented the clinical and genetic characteristics of 27 mainland Chinese late-onset Pompe patients from 24 families.

Results: GAA mutation analysis revealed 26 different mutations, including 10 that were novel. The allelic frequency of c.2238G > C (p.W746C) was found to be 27.08% in this patient group. Respiratory dysfunction was diagnosed in 10 of 11 patients who underwent pulmonary function evaluation, although only four required ventilator support at night.

Conclusions: Our findings indicate that c.2238G > C (p.W746C) is the most common mutation in mainland Chinese late-onset Pompe patients, as observed in Taiwanese patients. The novel mutations identified in this study expand the genetic spectrum of late-onset Pompe disease, and the prevalence of respiratory dysfunction highlights the importance of monitoring pulmonary function in late-onset Pompe patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Myopathological changes in Patient 2 (A and B), Patient 12 (C and D) and Patient 22 (E and F). H&E staining shows extensive vacuolation in many fibers in Patient 2 (A), but only a few vacuolar fibers in Patient 12 (C) and Patient 22 (E). Vacuolar fibers stained positive for glycogen with PAS (B, D and F).
Figure 2
Figure 2
GAA mutation spectrums in 27 Chinese late-onset Pompe patients. All described mutations are shown above (blue, UTR; purple, introns; orange, exons).
Figure 3
Figure 3
Exon 10 skipping in Patient 20. Muscle cDNA was amplified with the primers encompassing exon 9 and 10 that normally yield a 381-bp fragment. An additional 267-bp fragment was detected in Patient 20. The 114-bp difference is exactly the same with the size of exon 10.
Figure 4
Figure 4
Conservation of four novel missense mutations in different species.

References

    1. Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, Byrne BJ. The respiratory neuromuscular system in Pompe disease. Respir Respir Physiol Neurobiol. 2013;189:241–249. doi: 10.1016/j.resp.2013.06.007. - DOI - PMC - PubMed
    1. Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med. 2006;8:297–301. doi: 10.1097/01.gim.0000195896.04069.5f. - DOI - PubMed
    1. Müller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochmüller H, Schoser B. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord. 2007;17:698–706. doi: 10.1016/j.nmd.2007.06.002. - DOI - PubMed
    1. Laforêt P, Nicolino M, Eymard PB, Puech JP, Caillaud C, Poenaru L, Fardeau M. Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology. 2000;55:1122–1128. doi: 10.1212/WNL.55.8.1122. - DOI - PubMed
    1. Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ. The genotype–phenotype correlation in Pompe disease. Am J Med Genet C: Semin Med Genet. 2012;160C:59–68. doi: 10.1002/ajmg.c.31318. - DOI - PubMed

Publication types

LinkOut - more resources